Knee Osteoarthritis (Knee OA) Clinical Trial
— EPOPVerified date | December 2012 |
Source | University Hospital, Clermont-Ferrand |
Contact | n/a |
Is FDA regulated | No |
Health authority | France: Ministry of Health |
Study type | Interventional |
The benefit of preoperative rehabilitation treatment combining physiotherapy and targeted
education for patient undergoing Total Knee replacement (TKR) is now well known. Thus, there
is lack of validated booklet containing evidence based informations.
Our aim is to assess the impact of an evidence based education pre-operative booklet on
patient's knowledge and beliefs. The secondary objectives are to assess the impact of the
booklet on patient's satisfaction on the information received, the length of stay in
orthopedic surgery and the transfer rate to rehabilitation wards.
To show a difference of 2 points on the knowledge score (range 0-10) between the two groups,
with a = 0.05 and a power of 90%, we considered that 44 patients are needed. The evaluations
will take place at baseline, the day before surgery and 6 weeks post-surgery on knowledge
and beliefs scores at each visit and on a satisfaction score on the last one. Quantitative
data will be compared between groups by the Kruskal-Wallis and qualitative parameters via
Fisher exact test.
The study protocol was approved by the local Ethic Committee.
Status | Completed |
Enrollment | 44 |
Est. completion date | March 2012 |
Est. primary completion date | August 2011 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 55 Years to 75 Years |
Eligibility |
Inclusion Criteria: - Age ranging from 55 to 75 Planned total knee arthroplasty Exclusion Criteria: - Age under 55 or above 75 Patients institutionalized Patients who have received a total knee arthroplasty of the ipsilateral knee Patient not affiliated to a social security scheme (beneficiary or assignee) Patients with chronic inflammatory rheumatism Cognitive and behavioral issues Disorders of understanding and expression of the French language TKR on complex knee |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Prevention
Country | Name | City | State |
---|---|---|---|
France | CHU Clermont-Ferrand | Clermont-Ferrand |
Lead Sponsor | Collaborator |
---|---|
University Hospital, Clermont-Ferrand | Sanofi |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | knowledge score | at day 1 | Yes | |
Secondary | pain | Baseline | Yes | |
Secondary | Primary disability | Baseline | Yes | |
Secondary | Duration of hospitalization surgery | at day 1 | Yes | |
Secondary | Transfer rate in acute care and rehabilitation, and length of stay | at week 6 | Yes | |
Secondary | Patient's overall satisfaction towards the information received | at week 6 | Yes | |
Secondary | Patient's confidence in its own ability to achieve rehabilitation | at day-1 | Yes | |
Secondary | Patient's knowledge and beliefs about his condition | Baseline, at day-1 and week 6 | Yes |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04833946 -
To Assess the Effect of 336 Days Exposure of Paractin® on Pain & Disease Progression in Patients Suffering From Osteoarthritis of Knee Joint.
|
N/A |